Albert Bourla - Dec 15, 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
Susan E. Grant, by power of atty., for Albert Bourla
Stock symbol
PFE
Transactions as of
Dec 15, 2023
Transactions value $
$10,000,524
Form type
4
Date filed
12/19/2023, 12:35 PM
Previous filing
Dec 4, 2023
Next filing
Jan 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units SSP Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities $10M +376K +204.19% $26.63 559K Dec 15, 2023 Common Stock 376K Direct F1, F2, F3
transaction PFE Phantom Stock Units SSP Award $533 +20 +0% $26.63 559K Dec 15, 2023 Common Stock 20 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 This transaction constitutes an intra-plan transfer to acquire Pfizer stock units in the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan.
F3 These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.